CETP and myeloid sarcoma: Measurements of CETP activity in 4 batches of pooled plasma from MS patients (n = 6 per pool) and a pool of healthy controls (n = 6) showed an increase in the ability of plasma from MS patients to transfer phosphatidyl choline from VLDL to HDL (i.e., PLTP activity, see Figure 1 and supplemental data in the Supplementary Material available online at http://dx.doi.org/10.1155/2015/518654).